. . . . . . . "[This Phase I study, 'Ribozyme Gene Therapy of HIV-1 Infection' (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:52+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .